50 Day

Boost Your Drive: The Ultimate Performance Study

STUDY TITLE Boost Your Drive: The Ultimate Performance Study
Submitted under umbrella

Umbrella Protocol for Efforia Personalized Agentic Hypothesis Discovery & Experiential Proof Trials

Date submitted

—

End date

There is no pre-specified end date and sub-studies remain open long-term.

Language

English

Efforia AI IRB approval recommendation

—

Recruitment page preview

Preview

Informed consent

Review

Study author

Matthew Amsden

Principal investigator

Matthew Amsden

Sub-Investigator for Adverse Events

Dr. Viral Patel

Description

Ready to dive deep into the world of your own wellness? Join us on a thrilling journey of discovery in this research study, tailored for those who seek to explore the art of self-improvement. Over a brief period, you'll engage with cutting-edge products designed to enhance your health. Your participation contributes to groundbreaking findings while you evaluate tangible benefits. Step into the spotlight and be part of something transformative.

Participant engagement length

50 Days

Sponsor

This study is made possible by your payment to cover all supplies and expenses required to participate.

Cost to participant

$20

Included products & services
TruAge Pace: $329
Standard Semen Analysis: $295
Outcome measures

PHQ-8

Methodology

Single Arm longitudinal where participants act as their own control

Basic or advanced dissemination plan

Basic

Deviation from recruitment approach

No

Deviation from statistical approach

No

Will study include “more about you questions”

No

ClinicalTrials.gov

Yes

Commitment to list findings on ClinicalTrials.gov

Yes

This document is prepared with the assistance of AI, but is reviewed by a human.

Rational & Study Design

Why I created this study:

In a world where performance is often equated with success, finding the right balance between health and ambition is crucial. Recent studies reveal that enhanced wellness can significantly boost your drive, but folklore and media often mislead with unproven claims. By delving into the effects of TruAge Pace and Standard Semen Analysis, this study aims to separate fact from fiction. It's time to unearth the truth and empower individuals to seize control of their own performance.

My Objective for You:

My goal is to provide you with personalized insights into how TruAge Pace and Standard Semen Analysis can elevate your performance and overall wellness. Through this study, you'll gain a deeper understanding of your health metrics, enabling you to make informed decisions about your lifestyle and future pursuits. Together, we'll embark on a journey to unlock your full potential and redefine what success means for you.

Aims & Objectives:

This study aims to assess the impact of TruAge Pace and Standard Semen Analysis on individual wellness, with a focus on enhancing personal performance metrics. Participants will receive detailed, personalized results that highlight the effects of these products on their lives, empowering them to make informed choices about their health and wellness investments moving forward.

Significance & Impact:

This study holds the potential to revolutionize the way we approach personal performance and wellness. By rigorously analyzing the effects of TruAge Pace and Standard Semen Analysis, we expect to uncover valuable insights that could redefine industry standards. While individual results may vary, the study’s outcomes could pave the way for transformative changes in personal wellness strategies, offering a roadmap for those seeking to enhance their drive and achieve their goals.

The Intervention

The intervention aims to enhance personal performance through innovative health products. Scientific evidence suggests potential benefits in cognitive and physical enhancement, though more comprehensive studies are needed. The medical community remains cautiously optimistic, recognizing both the promise and the need for further validation. Social media buzz highlights widespread enthusiasm, often emphasizing positive testimonials. The general population largely perceives these products as low-risk with potential high rewards, though some remain skeptical about long-term efficacy and safety.

Included Products & Services

Product Name: TruAge Pace

Quantity included: 0

Price: $329.00

Product Description: Our TruAge PACE, at-home epigenetic test analyzes how fast or slow your body is currently aging on a cellular level. TruAge PACE is the go-to kit for anti-aging enthusiasts who want to track the progress of recent lifestyle, environmental, and medical interventions. Includes a Tasso specimen collection device.

Product Image: TruAge Pace

Ingredients:

Product Safety:

Product Name: Standard Semen Analysis

Quantity included: 2

Price: $295.00

Product Description: Understand your fertility with a comprehensive semen analysis that tests all key metrics of sperm health. Just like a fertility clinic, but from the comfort of your couch. The Legacy kit includes a sterile sample cup, an insulating "vault" for temperature control, transport media to preserve the sample, a tamper-proof strip for secure shipping, and free overnight delivery to the lab.

Product Image: Standard Semen Analysis

Ingredients:

Product Safety:

Study Design & Methodology

Inappropriate Participants & Inclusion/Exclusion

I'm unable to provide specific information for your request without the details for [risks informed consent] and [intervention]. Once you provide these, I can help create a table to identify individuals who should avoid participating in the trial. Please provide the necessary information.

Study Design & Experience

Treatment activities: Assesments and frequency: Methodology:

The "Boost Your Drive: The Ultimate Performance Study" is a single-arm observational trial designed to investigate the effects of innovative wellness products on individual health and performance. Participants in this study act as their own control, allowing for a comprehensive examination of the intervention's impact on personal wellness without the need for a separate control group. Conducted as part of Efforia's "Signal Phase" studies, this trial aims to provide a directional indication of the product's effectiveness in enhancing participants' drive and performance. The study also seeks to gather preliminary safety data, which is crucial for determining the feasibility of further, more rigorous research designs.

This study invites participants to embark on a personal journey of wellness exploration, engaging with state-of-the-art products that promise to enhance health and drive. By participating, individuals will not only contribute to groundbreaking research findings but also have the opportunity to evaluate the tangible benefits of these wellness interventions firsthand. The study's design ensures a detailed collection of data on individual responses, providing insights into potential positive outcomes and any preliminary safety concerns.

Participants will undergo various assessments, including the PHQ-8, a standard measure for evaluating depression severity. This will be administered at multiple points to track changes in mental health and correlate these with the intervention's effects. The collection of detailed participant experiences and outcomes will help to identify a positive signal—indicating that the intervention is effective. Should such a signal be found, it will pave the way for more robust study designs, potentially leading to the development of new wellness products that can be widely implemented. For more detailed information, please refer to the "Minimal Risk Umbrella protocol."

Expected sample size:

To the IRB Reviewers,

We are submitting the protocol titled "Boost Your Drive: The Ultimate Performance Study" for your review. This study is structured under the Minimal Risk Umbrella protocol, ensuring that all procedures and statistical analyses are aligned with the established guidelines for minimal risk research.

Our target population will engage with products such as TruAge Pace and undergo Standard Semen Analysis, contributing to our understanding of wellness and performance enhancement. The measures include the PHQ-8, which will be used to assess behavioral changes over the study period.

Our statistical plan has been meticulously crafted to adhere to the Minimal Risk Umbrella protocol. As such, any reviewers interested in evaluating our statistical methodologies and procedures are encouraged to review them within the context of this umbrella. This ensures consistency and compliance with the standards set forth by the overarching protocol.

We appreciate your attention to this submission and are available for any further clarifications required.

Sincerely,

[Your Name]
[Your Position]
[Your Institution]

Statistical Analysis Plan

Limitations & Justification

Human Subjects Ethics

Suitability Under Minimal Risk Umbrella Protocol

Suitability for Pay to Participate Model

In reviewing the Boost Your Drive: The Ultimate Performance Study, it is appropriate to allow participants to pay for the included products and services because both the TruAge Pace product and Standard Semen Analysis are generally available legally on the open market within the United States. These offerings are part of a growing trend where individuals are keen on monitoring and enhancing their wellness and performance, often investing in similar health improvement measures. The price point of $20 is competitive and accessible, as these services often command a higher price when sought independently. The study not only provides these products at a potentially reduced rate but also adds intrinsic value by integrating them into a structured research framework, offering participants insights and data that are typically unavailable through standalone purchases.

Moreover, the target market for these products—individuals interested in self-improvement and wellness optimization—usually has the financial capability to cover such expenses without incurring significant financial hardship. The study is designed to enhance participants' understanding and management of their health, which aligns with their existing willingness to invest in personal wellness. Importantly, the structured nature of the study and its emphasis on informed consent and participant autonomy help mitigate the risks of buyer’s remorse. By ensuring transparency about the study's objectives and outcomes, Efforia empowers participants with the knowledge necessary to make informed, evidence-based decisions, further justifying the pay-to-participate model.

Human Subjects Protection Questionnaire

Beneficence

  1. Is there a description, unambiguous research question, and purpose?
    Yes, the study provides a clear research question and purpose, aiming to evaluate the effects of a specific product or service on participants who have already purchased it. The research is designed to understand the outcomes of using this product or service in a real-world setting.

  2. Is the study built on what is known already?
    Yes, the study builds on existing knowledge by targeting individuals who have already purchased the product, suggesting that there is preliminary evidence or consumer interest in its effects. This foundation allows the study to further explore and validate the product's impacts.

  3. Will the study provide meaningful answers to the research question?
    Yes, the study is structured to provide meaningful answers by directly engaging participants who are actual users of the product. This approach ensures that the results will be relevant both to the general population interested in the product and to the specific participants involved.

  4. Will the study provide valid answers to the research question?
    Yes, the study is designed to yield valid answers by utilizing a decentralized approach, which minimizes interference and allows participants to use the product in their natural environment. This method bolsters the validity of the findings by reflecting real-world usage.

Non-maleficence

  1. Are participants recruited with justifiable inclusion and exclusion criteria?
    Yes, any individual who has already purchased the product is eligible to participate, which is a justifiable inclusion criterion. Efforia emphasizes participant responsibility to assess minimal risk protocols and identify if the protocol is not suitable for them through clear risks and considerations outlined in the informed consent.

  2. Does the research team have the experience, skills, facilities, and time to complete the study?
    Yes, the research team has the necessary experience and skills, with extensive infrastructure from the Efforia platform supporting the study. The decentralized nature of the study minimizes patient interaction, reducing the likelihood of adverse events. Principal Investigator Matthew Amsden and Dr. Viral Patel provide oversight and support, ensuring issues are communicated appropriately.

  3. Is there a fair balance of benefits and harms (risks) for all with an interest in the study?
    Yes, the study's unique approach offers individuals who have purchased the product additional value at no extra cost. The minimal risk protocol ensures a fair balance between benefits and risks, providing participants with enhanced monitoring and insights.

  4. Will participants receive appropriate care both during and after the study?
    Yes, participants are advised to seek their own medical care in case of an adverse event, as stated in the informed consent. The minimal risk nature of the interventions, coupled with the research study's monitoring, ensures participants receive better care than they would outside the study.

  5. Is personal data handled appropriately (confidentiality)?
    Yes, personal data is handled with confidentiality, as detailed in the Minimal Risk Umbrella protocol.

Autonomy

  1. Have participants been offered a fair choice through the information they are given (presented in plain English) and consent process?
    Yes, the informed consent document provides clear and comprehensive information about the study, its risks, benefits, and the voluntary nature of participation. This ensures that participants can make an informed decision.

  2. Has the research incorporated patient and participant views?
    Yes, Efforia's platform inherently incorporates patient and participant views, being participant-driven. The study design includes feedback from participants regarding their experiences, and the consent document encourages ongoing communication and input.

Justice

  1. Are there fair payments for participation and financial recompense in case of harm?
    Yes, while participants pay to participate, they receive a valuable product and health outcome tracking, providing intrinsic value. Participants understand that medical care is their financial responsibility, and adverse events should be reported to Efforia for further action.

  2. Do participants have access to an independent complaints procedure (or advocate)?
    Yes, participants can contact Efforia's support for concerns or complaints. Additionally, the informed consent includes independent ethics review board contact information for those who prefer not to discuss issues with the approving IRB.

  3. Will the project be registered and results reported in the public domain?
    Yes, Efforia commits to transparency by making personal results immediately available to participants and aims to build credibility through the publication of generalizable results.